Literature DB >> 24390629

Hemodialysis effects on phenytoin pharmacokinetics.

Sarah Bezzaoucha1, Amine Merghoub, Caroline Lamarche, Vincent Pichette, Jean-Philippe Lafrance, Louis-Philippe Laurin, Michel Vallée, Robert Robitaille, Martine Leblanc, Robert Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24390629     DOI： 10.1007/s00228-013-1628-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Hemodialysis of phenytoin in a uremic patient.

Authors:  D S Adler; E Martin; J G Gambertoglio; T N Tozer; J P Spire
Journal:  Clin Pharmacol Ther       Date:  1975-07       Impact factor: 6.875

2.  Significant removal of phenytoin during high flux dialysis with cellulose triacetate dialyzer.

Authors:  D Frenchie; B Bastani
Journal:  Nephrol Dial Transplant       Date:  1998-03       Impact factor: 5.992

3.  Renal function and therapeutic concentrations of phenytoin.

Authors:  D F Liponi; M E Winter; T N Tozer
Journal:  Neurology       Date:  1984-03       Impact factor: 9.910

4.  The effect of haemodialysis on the binding capacity of albumin.

Authors:  S H Dromgoole
Journal:  Clin Chim Acta       Date:  1973-07-27       Impact factor: 3.786

5.  Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uremia treated with hemodialysis. Role of uremic compounds.

Authors:  A Dasgupta; A Abu-Alfa
Journal:  Am J Clin Pathol       Date:  1992-07       Impact factor: 2.493

6.  Audit of a monitoring service for free phenytoin.

Authors:  G M Peterson; S McLean; R J von Witt; K S Millingen
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.